IL207749A0 - Methods to inhibit tumor cell growth by using proton pump inhibitors - Google Patents

Methods to inhibit tumor cell growth by using proton pump inhibitors

Info

Publication number
IL207749A0
IL207749A0 IL207749A IL20774910A IL207749A0 IL 207749 A0 IL207749 A0 IL 207749A0 IL 207749 A IL207749 A IL 207749A IL 20774910 A IL20774910 A IL 20774910A IL 207749 A0 IL207749 A0 IL 207749A0
Authority
IL
Israel
Prior art keywords
methods
cell growth
tumor cell
proton pump
inhibit tumor
Prior art date
Application number
IL207749A
Original Assignee
Bio Quant Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Quant Inc filed Critical Bio Quant Inc
Publication of IL207749A0 publication Critical patent/IL207749A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL207749A 2008-03-04 2010-08-23 Methods to inhibit tumor cell growth by using proton pump inhibitors IL207749A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/002918 WO2009110862A1 (en) 2008-03-04 2008-03-04 Methods to inhibit tumor cell growth by using proton pump inhibitors

Publications (1)

Publication Number Publication Date
IL207749A0 true IL207749A0 (en) 2010-12-30

Family

ID=41056268

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207749A IL207749A0 (en) 2008-03-04 2010-08-23 Methods to inhibit tumor cell growth by using proton pump inhibitors

Country Status (9)

Country Link
EP (1) EP2254557A4 (en)
JP (1) JP2011513396A (en)
KR (1) KR20100123750A (en)
AU (1) AU2008352018A1 (en)
CA (1) CA2717481A1 (en)
IL (1) IL207749A0 (en)
MX (1) MX2010009795A (en)
NZ (1) NZ587941A (en)
WO (1) WO2009110862A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2548555A1 (en) * 2011-07-18 2013-01-23 Fondazione IRCCS Istituto Nazionale dei Tumori Proton pump inhibitors as immunomodulators
CN113667646A (en) * 2021-08-27 2021-11-19 潘思源 Renal carcinoma sorafenib drug-resistant cell strain and construction method and application thereof
WO2023048508A1 (en) * 2021-09-23 2023-03-30 국립암센터 Pharmaceutical composition for preventing or treating cancer, containing browned material of omeprazole
CN115475166B (en) * 2022-09-13 2023-11-21 中南大学湘雅医院 Application, medicine and preparation method of revaprazan compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080917A1 (en) * 2001-04-06 2002-10-17 Forskarpatent I Uppsala Ab Novel use of proton pump inhibitors
KR20050055415A (en) * 2003-12-08 2005-06-13 함기백 Anticancer agent containing benzimidazole derivatives as an effective component
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors

Also Published As

Publication number Publication date
WO2009110862A1 (en) 2009-09-11
AU2008352018A1 (en) 2009-09-11
CA2717481A1 (en) 2009-09-11
EP2254557A4 (en) 2011-03-30
JP2011513396A (en) 2011-04-28
EP2254557A1 (en) 2010-12-01
KR20100123750A (en) 2010-11-24
MX2010009795A (en) 2010-12-21
NZ587941A (en) 2012-11-30

Similar Documents

Publication Publication Date Title
DK2411028T3 (en) THERAPY TO PROMOTE CELL GROWTH
IL222454A0 (en) Improved cell cultivation process
IL212471A0 (en) Cell transplantation
SI2645996T1 (en) Method for producing a pharmaceutical composition comprising proton pump inhibitors
IL222452A0 (en) Improved cell culture medium
ZA201203653B (en) Method for producing butanol using extractive fermentation with electrolyte addition
PL2283113T3 (en) Pluripotent cells
EP2381936A4 (en) Pathways to generate hair cells
GB2480550B (en) Sip anchor points to populate common communication logs
DK3572100T3 (en) COMPOSITION FOR STIMULATING EPITLE CELL GROWTH
IL222453A0 (en) Improved cell culture medium
HK1248242A1 (en) Animal cell culturing method
EP2326716A4 (en) Enhanced animal cell growth using ultrasound
EP2300608A4 (en) Methods to treat solid tumors
EP2641966A4 (en) Vitrificated storage solution for cells
HK1184451A1 (en) 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors 4--2--1--4-
EP2660357A4 (en) Ion-exchange membrane method electrolytic cell
GB0800524D0 (en) Cell culture system
EP2639365A4 (en) Water intake structure for water-storing float
IL207749A0 (en) Methods to inhibit tumor cell growth by using proton pump inhibitors
ZA201103131B (en) Methods to reduce b-helper t cells to treat autoimmune diseases
EP2424527B8 (en) Mast cell stabilizers to prevent or treat laminitis
EP2758551A4 (en) Systems and methods for individualized functional genomic profiliing related to cancer cell growth
TWI371887B (en) Method for supplying fuel to fuel cell
PT2316036E (en) Stimulated cell standards